Drug management of inflammatory bowel disease.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011349:Proctitis / Q000188:drug therapy; D012460:Sulfasalazine / Q000627:therapeutic use*; D014456:Ulcer
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D004338:Drug Combinations; C028423:Salazopyrine; D012460:Sulfasalazine; D000324:Adrenocorticotropic Hormone; D001379:Azathioprine; D005944:Glucosamine; D004205:Cromolyn Sodium